Since Bcl-6 is the most frequently involved oncogene in diffuse large B cell lymphoma, the Bcl-6 inhibitor 79-6 was developed to suppress lymphoma cell growth [33]. Here, BCL6 is linked to diffuse large B-cell lymphoma.